Table 2.
A. N-Acylethanolamines | ||
---|---|---|
NAE | Receptors(s) | Reference |
Anandamide | CB1, CB2, PPARα, PPARγ, TRPV1, and TRPM8 |
[6,13-16] |
N-Dihomo-γlinolenoylethanolamine | CB1 and CB2 | [119] |
5Z,8Z,11Z- Eicosatrienoylethanolamine |
CB1 and CB2 | [119] |
N-Oleoylethanolamine | PPARα, PPARγ, TRPV1, and GPR119 | [6,15,24] |
N-Palmitoylethanolamine | PPARα, GPR55 | [15,27] |
N-Linolenoylethanolamine | TRPV1 | [6] |
N-Linoleoylethanolamine | TRPV1 | [6] |
B. N-Acyldopamines | ||
NDA | Receptors(s) | Reference |
N-Arachidonoyldopamine | CB1, TRPV1, and non-CB1/CB2 GPCR (in the aorta) |
[38,39,41] |
N-Oleoyldopamine | PPARα, PPARγ, and TRPV1 | [38,39] |
C. N-Acylamino acidsb,c | ||
NAA Receptors(s) | Reference | N-Arachidonoyltaurine |
N-Arachidonoyltaurine | TRPV1 and TRPV4 | [74] |
N-Arachidonoylglycinec | GPR18 | [75] |
D. Primary Fatty Acid Amides | ||
PFAM | Receptors(s) | Reference |
Oleamide | GABAA receptor, 5-HT2A, 5-HT2C, and 5-HT7 | [120-122] |
In some cases, the indicated fatty acid amide has not been demonstrated to bind to the listed target by direct binding, but instead has been shown to be an agonist or antagonist to the target using a reporter assay. For exact details, the reader is pointed to the cited references.
While N-acetylglutamate is not formally a fatty acid amide, this N-acylamino acid binds a protein target as it is an allosteric activator of carbamoylphosphate synthetase I.
Fatty acid conjugation to amino acids serves largely in the detoxification and execretion of xenobiotic carboxylates. Thus, many of the N-acylamino acids are likely to bind to a membrane-bound transporter. For example, Wiles et al. [78] have recently shown that N-arachidonoylglycine inhibits the GLYT2a glycine transporter.